These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32158211)

  • 21. Common and Distinct Alterations of Cognitive Function and Brain Structure in Schizophrenia and Major Depressive Disorder: A Pilot Study.
    Ma M; Zhang Y; Zhang X; Yan H; Zhang D; Yue W
    Front Psychiatry; 2021; 12():705998. PubMed ID: 34354618
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
    Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
    Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria.
    Holmberg D; Franzén-Röhl E; Idro R; Opoka RO; Bangirana P; Sellgren CM; Wickström R; Färnert A; Schwieler L; Engberg G; John CC
    Malar J; 2017 Jul; 16(1):303. PubMed ID: 28754152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immune-kynurenine pathway in social anxiety disorder.
    Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
    Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imbalanced kynurenine pathway in schizophrenia.
    Kegel ME; Bhat M; Skogh E; Samuelsson M; Lundberg K; Dahl ML; Sellgren C; Schwieler L; Engberg G; Schuppe-Koistinen I; Erhardt S
    Int J Tryptophan Res; 2014; 7():15-22. PubMed ID: 25288889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
    Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
    Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficits of Tactile Passive Perception Acuity in Patients With Schizophrenia.
    Liu D; Fan HZ; Zhao WX; Wang YH; Li D; Wu JL; Yan TY; Tan SP
    Front Psychiatry; 2020; 11():519248. PubMed ID: 33192644
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study.
    Li S; Chen D; Xiu M; Li J; Zhang XY
    J Psychiatr Res; 2021 Feb; 134():39-47. PubMed ID: 33360223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
    Meier TB; Drevets WC; Teague TK; Wurfel BE; Mueller SC; Bodurka J; Dantzer R; Savitz J
    Brain Behav Immun; 2018 Jan; 67():59-64. PubMed ID: 28867283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
    Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
    Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Stone WS; Mesholam-Gately RI; Giuliano AJ; Woodberry KA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; McCarley RW; Heinssen R; Green MF; Nuechterlein K; Seidman LJ
    Schizophr Res; 2016 Apr; 172(1-3):106-13. PubMed ID: 26896388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia.
    Peng XJ; Hei GR; Yang Y; Liu CC; Xiao JM; Long YJ; Huang J; Zhao JP; Wu RR
    Front Psychiatry; 2021; 12():638773. PubMed ID: 33716832
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance.
    Chiappelli J; Pocivavsek A; Nugent KL; Notarangelo FM; Kochunov P; Rowland LM; Schwarcz R; Hong LE
    JAMA Psychiatry; 2014 Jul; 71(7):761-8. PubMed ID: 24806441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.
    Pocivavsek A; Wu HQ; Elmer GI; Bruno JP; Schwarcz R
    Eur J Neurosci; 2012 May; 35(10):1605-12. PubMed ID: 22515201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia.
    Yang M; Gao S; Zhang X
    Transl Psychiatry; 2020 Nov; 10(1):368. PubMed ID: 33139736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.
    Plitman E; Iwata Y; Caravaggio F; Nakajima S; Chung JK; Gerretsen P; Kim J; Takeuchi H; Chakravarty MM; Remington G; Graff-Guerrero A
    Schizophr Bull; 2017 Jul; 43(4):764-777. PubMed ID: 28187219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.